Ciprofloxacin in the treatment of Mycobacterium fortuitum infection of the peroneal tendons. A case report

TA Binning Department of Podiatric Surgery, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.

Search for other papers by TA Binning in
Current site
Google Scholar
PubMed
Close
,
JM Karlin Department of Podiatric Surgery, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.

Search for other papers by JM Karlin in
Current site
Google Scholar
PubMed
Close
,
D Klein Department of Podiatric Surgery, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.

Search for other papers by D Klein in
Current site
Google Scholar
PubMed
Close
,
BL Scurran Department of Podiatric Surgery, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.

Search for other papers by BL Scurran in
Current site
Google Scholar
PubMed
Close
, and
RA Cooke Department of Podiatric Surgery, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.

Search for other papers by RA Cooke in
Current site
Google Scholar
PubMed
Close

In the case reported, M. fortuitum was sensitive in vitro to amikacin, erythromycin, tobramycin, and ciprofloxacin. Because the patient did not respond to long-term therapy with amikacin and erythromycin, an experimental antibiotic, ciprofloxacin, was tried. Only after extensive surgical debridement and 2 1/2 months of oral ciprofloxacin therapy was the infection eradicated and wound healing obtained. The authors conclude that a wound that has reopened, but remains indolent, exudes a clear, serous drainage and responds poorly to antibiotics should suggest a possible mycobacterial infection. Combination antibiotic therapy is recommended because of the high rate of relapse and development of resistance to drugs. Extensive surgical debridement of all infected tissue remains the primary treatment. The therapeutic value of ciprofloxacin and other newer antibiotics in the treatment of mycobacterial infection is promising.

Save